Contact

Linkcare, collaborative medicine platform, receives €5M round and moves into China


, , , ,
Integral service around a transaction
BY : Diego GutiérrezJune Thu, 2017
Linkcare, which was born in Hospital Clínic, is a collaborative medicine platform. The company has just agreed the entry into its shareholding of Guangzhou Global Star Investment, a Chinese fund that will inject about €5M for a majority stake, conditional on the company moving its headquarters to the business park in Canton.
Linkcare, collaborative medicine platform, receives €5M round and moves into China
About Linkcare

Linkcare, started as a telemedicine software company and has evolved into a collaborative medicine platform.

The company has three lines of business. Integrated care units (to design, share and implement integrated care protocols that allow all doctors, specialists and caregivers treating a patient to collaborate; in Spain, the platform is used for example in the Basque public health service). Another is the tool for research teams (to conduct and monitor clinical trials with patients in different countries) or collaborative research. And the third is the so-called collaborative medicine, which means the participation in the treatment protocols of caregivers or relatives to monitor (blood pressure, nutrition).

Behind this project is Jim Martínez Roldán (doctor and Esade-trained, he created the artificial vision technology company CTA in the United States in 1985 and sold it to Indra in 2007). "In 2010, I decided to see what was going on in China, just as I had looked in the US when I was young", and he explains that over the years he has built up a wide network of contacts there. At the same time, Roldán joined Linkcare as a business angel, a company of which he has become CEO, with José Manuel Sánchez as general manager.

Linkcare had a turnover of more than 350,000 euros in 2016, and for 2017 it expects to reach 500,000 euros, 15% in Spain, and the rest in other European countries, and in China. In China, the company already has two activities, Roldán explains. One, in Beijing, of collaborative community care for the care of the elderly, inspired by the Radar programme in Barcelona, and which has financial support from the CDTI; and the other, using the platform for the training of 1.3M, and now a service to 20,000 doctors in Tianjin.

Linkcare had already received a €300,000 round in 2015 from Esade Ban.

About the operation

Now the Chinese fund Guangzhou Global Star Investment, has decided to invest €5M in the company, becoming the main shareholder, with the condition that its headquarters will be located in the business park of Canton. This transaction enables Linkcare to increase its presence in the Chinese healthcare market. The Barcelona headquarters will remain the operational base for Europe and America.

Spanish companies on which China has set its sights

In 2016, China overtook the US as the world's largest buyer, investing more than €200 billion to take positions in companies around the globe.

Of all the money disbursed from Asia, almost 89 billion has ended up in Europe, a record amount and three times the amount invested last year. But the distribution between countries has been uneven. China has taken a step backwards in Italy, where its presence in corporate operations has plummeted, while in France and the UK it has remained high, although far from its best moments.

In Spain, although Chinese participation is still small, in 2016 it was 14 times higher than in 2015.This growth has been partly due to the sale by ACS of its subsidiary Urbaser to China's CNTY, for which the latter will pay a price of between 1,164 and 1,399 million euros.

This purchase, which has not yet materialised, has been joined by 10 other transactions of Chinese companies in Spain so far in 2016, according to Dealogic's register. The canning company Albo has been owned by Shanghai Kaichuang since this summer, while Ángel Corcóstegui's private equity fund (Magnum Capital) set its sights on the also Chinese JSTI to sell its stake in Eptisa Servicios de Ingeniería.

Other posts that may interest you

Doctoralia merges with Docplanner to form world's largest healthcare marketplace

Top Doctors receives another €3M round, led by a Russian investor.
If you are looking for investors, you want to buy or selling a companyplease contact us. Abra-Invest has a team of experts in each area at your disposal. Call +34 946424142 or fill in the contact form.

 

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
closearrow-circle-o-downchevron-downcrossmenu